Drug profile · INN
cisapride monohydrate
PROPULSID QUICKSOLV
cisapride monohydrate (PROPULSID QUICKSOLV) is a serotonin 4 (5-ht4) receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — cisapride monohydrate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
cisapride monohydrate (PROPULSID QUICKSOLV) is a serotonin 4 (5-ht4) receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 4 (5-HT4) receptor agonist
Primary target: 5-hydroxytryptamine receptor 4
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is cisapride monohydrate?
cisapride monohydrate (PROPULSID QUICKSOLV) is a serotonin 4 (5-ht4) receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for cisapride monohydrate?
PROPULSID QUICKSOLV is a marketed brand name for cisapride monohydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cisapride monohydrate?
cisapride monohydrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.